Stevanato Group Balance Sheet Health
Finanzielle Gesundheit Kriterienprüfungen 5/6
Stevanato Group has a total shareholder equity of €1.3B and total debt of €301.3M, which brings its debt-to-equity ratio to 22.7%. Its total assets and total liabilities are €2.2B and €872.8M respectively. Stevanato Group's EBIT is €170.0M making its interest coverage ratio 47.8. It has cash and short-term investments of €80.1M.
Wichtige Informationen
22.7%
Verhältnis von Schulden zu Eigenkapital
€301.26m
Verschuldung
| Zinsdeckungsgrad | 47.8x |
| Bargeld | €80.12m |
| Eigenkapital | €1.32b |
| Gesamtverbindlichkeiten | €872.83m |
| Gesamtvermögen | €2.20b |
Jüngste Berichte zur Finanzlage
We Think Stevanato Group (NYSE:STVN) Is Taking Some Risk With Its Debt
Oct 23
Does Stevanato Group (NYSE:STVN) Have A Healthy Balance Sheet?
Jul 23Recent updates
We Think Stevanato Group (NYSE:STVN) Is Taking Some Risk With Its Debt
Oct 23Is Stevanato Group S.p.A. (NYSE:STVN) Worth US$19.3 Based On Its Intrinsic Value?
Aug 21Stevanato Group S.p.A. (NYSE:STVN) Looks Just Right With A 28% Price Jump
Jul 25Does Stevanato Group (NYSE:STVN) Have A Healthy Balance Sheet?
Jul 23Stevanato: Destock Pressures, Long-Term Upside
May 29Stevanato Group S.p.A. Earnings Missed Analyst Estimates: Here's What Analysts Are Forecasting Now
May 12Stevanato Group S.p.A.'s (NYSE:STVN) Share Price Matching Investor Opinion
May 07Stevanato Group's (NYSE:STVN) Solid Earnings May Rest On Weak Foundations
Mar 15Stevanato: Destocking And Valuation Risk (Rating Downgrade)
Mar 12Is Stevanato Group S.p.A. (NYSE:STVN) Expensive For A Reason? A Look At Its Intrinsic Value
Feb 09Stevanato: Guidance Reiterated And Supportive Revenue Growth
Nov 22Is Stevanato Group S.p.A. (NYSE:STVN) Worth US$31.6 Based On Its Intrinsic Value?
Oct 22Stevanato: Secular Tailwinds In Biologics Support Downstream Demand
Sep 15Stevanato Group: Undeniable Quality, But Lacking Upside
Jun 14Stevanato Group S.p.A. Just Beat EPS By 5.1%: Here's What Analysts Think Will Happen Next
Mar 05Stevanato Group and Transcoject to provide pre-fillable syringe polymer options for pharma
Jan 24There's Reason For Concern Over Stevanato Group S.p.A.'s (NYSE:STVN) Price
Dec 28Stevanato Group Non-GAAP EPS of $0.14 beats by $0.01, revenue of $245.3M in-line
Nov 08An Intrinsic Calculation For Stevanato Group S.p.A. (NYSE:STVN) Suggests It's 49% Undervalued
Aug 01A Look At The Intrinsic Value Of Stevanato Group S.p.A. (NYSE:STVN)
Apr 19Analyse der Finanzlage
Kurzfristige Verbindlichkeiten: STVN's short term assets (€869.7M) exceed its short term liabilities (€499.6M).
Langfristige Verbindlichkeiten: STVN's short term assets (€869.7M) exceed its long term liabilities (€373.3M).
Geschichte und Analyse des Verhältnisses von Schulden zu Eigenkapital
Verschuldungsgrad: STVN's net debt to equity ratio (16.7%) is considered satisfactory.
Schulden abbauen: Insufficient data to determine if STVN's debt to equity ratio has reduced over the past 5 years.
Schuldendeckung: STVN's debt is well covered by operating cash flow (45.7%).
Zinsdeckung: STVN's interest payments on its debt are well covered by EBIT (47.8x coverage).